Merial - Boehringer Ingelheim

With an eye on the changing global issues that are driving our sector, our attention focuses above all on one critical question: What does the world need from an animal health company? From pharmaceutical drugs and biological vaccines to wellness products, we develop smart solutions for a range of species and animal health issues. We’ve pioneered many game-changers in veterinary medicine – and we’re looking to our customer`s needs to guide us into the future. Rooted in some of the most important historic milestones in biological science and pharmaceutical products, we have always been a true innovator in the field of animal health.

Company details

12, rue André Huet, CS 20031 , Reims cedex , 51721 France

More Office Locations Locations Served

Business Type:
Manufacturer
Industry Type:
Agriculture - Livestock
Market Focus:
Globally (various continents)
Year Founded:
1997
Employees:
Over 1000

Since our arrival in Canada in 1972 we have played a varied and integral role in the health of Canadians. We are committed to finding medical breakthroughs and investing in research, development and medicine for therapies which fulfill unmet medical needs.

Through our participation in medical and pharmaceutical research, both in Canada and worldwide, we have contributed to significant improvements in healthcare and developed innovative and costeffective medicines. We have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of our work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson's disease and HIV/AIDS.

We are constantly seeking new and better ways to treat people and animals. In the space of just two years, we have introduced several new products and have a number of new compounds in the pipeline. We have participated in joint ventures with other top multinational pharmaceutical companies - ventures that have improved quality of life for many thousands of Canadians and have perhaps saved the lives of thousands more. Our Vetmedica Division is an accomplished leader in veterinary medicine, offering innovative solutions in biologicals and specialty pharmaceuticals for beef and dairy cattle, swine, companion animals and horses.

While our German parent company stands among the world’s 20 largest human pharmaceutical research and development businesses, it has remained a family held company for over a century. As our ownership has remained unchanged, so have our guiding principles. Since our founding, we have practiced excellence, innovation and value in the discovery of medicines and services, and we have always acted in the firm knowledge that people and service are our priorities.

  • Annual Press Conference

Business Segments World Leader Across Species
Organized in two strategic business units, Boehringer Ingelheim Animal Health delivers a large and innovative portfolio of products and services to prevent disease and improve the health and productivity of animals around the world.

Business Segments World Leader Across Species
Organized in two strategic business units, Boehringer Ingelheim Animal Health delivers a large and innovative portfolio of products and services to prevent disease and improve the health and productivity of animals around the world.

Did You Know...
To this day, the top two sellers the animal health industry has ever produced are from Boehringer Ingelheim: our family of ivermectin-based parasticides and our FRONTLINE flea and tick products - with literally billions of doses administered since the 1970s.

Value through Innovation is the central concept of our corporate vision. Together with the corporate culture concept 'AAI', this is the driver of the corporate culture.

Value through Innovation: The company has for generations adhered to this principle in all its activities. It is Boehringer Ingelheim's goal to act with long-term responsibility and in a value-based manner. Boehringer Ingelheim is guided in its corporate responsibility by the company's stated core principles.

We are a different kind of company and we have the freedom to invest in innovations that help Canadians continue to do the things that matter most to them. We are powered by our people, their passion for innovation and their desire to better the lives of our patients, whether they are on two legs or four. That’s how BI Innovates.